Advanced Drug Delivery Systems
PEGylation is a transformative strategy in the development of advanced drug delivery systems. By conjugating drugs with PEG, their systemic circulation time is significantly prolonged, reducing the frequency of administration and improving patient compliance. This is particularly beneficial for sensitive molecules like proteins, peptides, and nucleic acids, protecting them from enzymatic degradation. Furthermore, PEGylated nanocarriers, such as liposomes and micelles, enable targeted drug delivery to specific tissues or tumor sites, minimizing off-target toxicity and enhancing therapeutic efficacy for treatments like anti-cancer therapies and anti-diabetic medications.